A Battle Inside The Food And Drug Administration Has Gone Public

The Wall Street Journal reports, a senior regulator is arguing with his bosses over the safety of popular blood pressure medicines. Thomas Marciniak urges FDA to issue warnings that the drugs increase the likelihood of cancer. Ellis Unger, chief of the drug evaluation unit, disagrees. Both cite 2010 studies involving 68,000 patients. But they come to different conclusions. The Journal quoted an exchange of caustic emails between the two. Marciniak accuses Unger of ignoring the possibility of a 30 percent increase in the incidence of cancer.